Skip to main content

Duke Cancer Institute

Duke Cancer Institute Logo
  • DCI Blog
  • Events
  • DCI Members
  • Contact
  • Give
Cancer Types and Programs
  • Primary Brain Cancer
  • Brain and Spine Metastasis
  • Breast Cancer
  • Endocrine Neoplasia
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hematologic Malignancies and Cellular Therapy
  • Immunotherapy
  • Melanoma and Advanced Skin Cancers
  • Molecular Tumor Board
  • Oncologic Reconstructive Surgery
  • Pancreatic Cancer
  • Pediatric Cancers
  • Prostate and Urologic Cancers
  • Sarcoma
  • Thoracic Cancer
  • Thyroid Cancer
Supportive Care
  • Supportive Care and Survivorship Center
Research
  • Cancer Registry
  • Clinical Trials
  • Research Programs
  • Shared Resources
Education and Training
  • Office of Cancer Research Training and Education Coordination
About DCI
  • DCI Overview
  • DCI Members
  • Nursing
  • Careers
  • Community Outreach and Engagement
  • Contact
  • DCI blog
  • Events
Get Involved
  • Giving Opportunities
  • Benefits and Special Events
  • Breakthroughs Magazine
Make an Appointment
  • Blogs
Prostate

Sound Waves Could Provide New Tool To Fight Cancer

Published

July 03, 2018

Written By

Default DCI member profile image

Ken Kingery

Pratt School of Engineering

Topics

  • Center for Prostate and Urologic Cancers
  • Prostate Cancer

Share

Share This Page

Twitter

Print Page Or Copy Link Url

Copied to clipboard

Related News

headshot of Daniel George
News Mention

Capivasertib Brings Biomarker-Driven Strategy to Hormone-Sensitive Prostate Cancer | ASCO GU

February 27, 2026
Pharmacy Times
headshot of Daniel George
News Mention

Truqap Plus Zytiga Maintains Quality of Life in PTEN-Deficient Prostate Cancer

February 26, 2026
Cure Today

Related News

headshot of Daniel George
News Mention

Capivasertib Brings Biomarker-Driven Strategy to Hormone-Sensitive Prostate Cancer | ASCO GU

February 27, 2026
Pharmacy Times
headshot of Daniel George
News Mention

Truqap Plus Zytiga Maintains Quality of Life in PTEN-Deficient Prostate Cancer

February 26, 2026
Cure Today
Duke Cancer Institute
Facebook Instagram Twitter YouTube RSS
  • Cancer Types
  • Primary Brain Cancer
  • Brain and Spine Metastasis
  • Breast Cancer
  • Endocrine Neoplasia
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hematologic Malignancies and Cellular Therapy
  • Melanoma and Advanced Skin Cancers
  • Pediatric Cancers
  • Prostate and Urologic Cancers
  • Sarcoma
  • Thoracic Cancer
  • Cancer Therapies
  • Immunotherapy
  • Molecular Tumor Board
  • Supportive Care
  • Supportive Care and Survivorship Center
  • Research
  • Cancer Registry
  • Clinical Trials
  • Research Programs
  • Shared Resources
  • Education and Training
  • About DCI
  • DCI Members
  • Nursing
  • Careers
  • Community Outreach and Engagement
  • Give To DCI
  • Benefits and Special Events
  • Breakthroughs Magazine
  • DCI Blog
  • Primary Brain Cancer
  • Brain and Spine Metastasis
  • Breast Cancer
  • Endocrine Neoplasia
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hematologic Malignancies and Cellular Therapy
  • Melanoma and Advanced Skin Cancers
  • Pediatric Cancers
  • Prostate and Urologic Cancers
  • Sarcoma
  • Thoracic Cancer
  • Immunotherapy
  • Molecular Tumor Board
  • Supportive Care and Survivorship Center
  • Cancer Registry
  • Clinical Trials
  • Research Programs
  • Shared Resources
Education and Training
  • DCI Members
  • Nursing
  • Careers
  • Community Outreach and Engagement
  • Benefits and Special Events
  • Breakthroughs Magazine
DCI Blog
  • Website Privacy Policy
  • Sitemap
  • Leading with Heart: Serving Humanity
  • Notice of Nondiscrimination
  • Notice of Privacy Practices
  • Terms and Conditions
  • Accessibility
  • © DUKE CANCER INSTITUTE 2026
Back to Top